Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Early Phase 1
1(25.0%)
4Total
N/A(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05771844Not ApplicableRecruiting

Home Sleep Therapy for Older Adults With MCI

Role: lead

NCT05970276Not ApplicableUnknown

Non-Invasive At-Home Sleep Therapy System

Role: lead

NCT04461769Early Phase 1Completed

Electrical Synchronization of Slow Oscillations to Enhance Deep Sleep

Role: lead

NCT03751982Not ApplicableUnknown

Closed Loop TES for Enhancing Slow Wave Sleep

Role: lead

All 4 trials loaded